EMPA-REG Outcome: results that question

被引：0
|
作者：
Pouchain, Denis [1 ]
机构：
[1] UFR Tours, Dept Univ Med Gen, Tours, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2016年 / 27卷 / 128期
关键词：
Empagliflozin; Hypoglycemic agents; Randomized controlled trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 282
页数：5
相关论文
共 50 条
  • [1] Bladder cancer in the EMPA-REG OUTCOME trial
    Kohler, Sven
    Lee, Jisoo
    Georges, Jyothis T.
    Inzucchi, Silvio E.
    Zinman, Bernard
    DIABETOLOGIA, 2017, 60 (12) : 2534 - 2535
  • [2] Asian Perspective of the EMPA-REG OUTCOME Study
    Bando, Yasuko K.
    Murohara, Toyoaki
    CIRCULATION JOURNAL, 2017, 81 (02) : 155 - 157
  • [3] Bladder cancer in the EMPA-REG OUTCOME trial
    Sven Kohler
    Jisoo Lee
    Jyothis T. George
    Silvio E. Inzucchi
    Bernard Zinman
    Diabetologia, 2017, 60 : 2534 - 2535
  • [4] EMPA-REG OUTCOME: The Endocrinologist's Point of View
    Perreault, Leigh
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01): : S48 - S52
  • [5] EMPA-REG OUTCOME: The Endocrinologist's Point of View
    Perreault, Leigh
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06): : S51 - S56
  • [6] EMPA-REG OUTCOME: The Cardiologist's Point of View
    Pham, Son V.
    Chilton, Robert J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01): : S53 - S58
  • [7] EMPA-REG OUTCOME: The Cardiologist's Point of View
    Pham, Son V.
    Chilton, Robert
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06): : S57 - S62
  • [8] EMPA-REG OUTCOME: The Nephrologist's Point of View
    Wanner, Christoph
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06): : S63 - S72
  • [9] Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
    Ampudia-Blasco, Francisco Javier
    Romera, Irene
    Arino, Bernat
    Gomis, Ramon
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2017, 10 : 23 - 26
  • [10] Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial
    Alzaid, Aus
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (06) : 324 - 327
12345